Anixa Biosciences ANIX
NASDAQ ANIX
$3.59 -0.12 (-3.23%)
At close: Aug 20, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Revenue (2010 - 2023)

Anixa Biosciences' (ANIX) quarterly Revenue came in at $210000.0 in Q2 2023, up 21100.0% on a QoQ basis from -$1000.0 in Q4 2021.

Anixa Biosciences (ANIX) Revenue (2010 - 2023) Analysis & Trends

Anixa Biosciences (ANIX) has 11 years of Revenue data on file, last reported at $210000.0 in Q2 2023.

  • Quarterly Revenue changed N/A year-over-year to $210000.0 in Q2 2023, while the trailing twelve-month figure through Oct 2023 was $209000.0 (changed N/A YoY) and the FY2023 annual result came in at $210000.0, changed N/A from the prior year.
  • Revenue rose to $210000.0 in Q2 2023, from -$1000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $513000.0 in Q1 2021 to a low of -$1000.0 in Q4 2021.
  • A 3-year average of $243000.0 and a median of $230000.0 in 2019 frame the typical range for Revenue.
  • The widest YoY moves for Revenue: up 66.67% in 2019, down 66.67% in 2019.
  • Tracing ANIX's Revenue over 3 years: stood at $250000.0 in 2019, then plunged by 100.4% to -$1000.0 in 2021, then surged by 21100.0% to $210000.0 in 2023.
  • The last three Revenue figures came in at $210000.0 (Q2 2023), -$1000.0 (Q4 2021), and $513000.0 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.52 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.29 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 425.49 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 674.14 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.06 Bn
10 Anixa Biosciences 121.44 Mn 121.44 Mn - -

Historic Data

Download Data
DateValue
Apr 30, 2023 210,000.00
Oct 31, 2021 -1,000.00
Jan 31, 2021 513,000.00
Apr 30, 2019 250,000.00
Jul 31, 2018 362,500.00
Apr 30, 2018 750,000.00
Jul 31, 2017 362,500.00
Oct 31, 2016 200,000.00
Jul 31, 2016 100,000.00
Jul 31, 2015 95,000.00
Apr 30, 2015 25,000.00
Jan 31, 2015 9.14 Mn
Oct 31, 2014 1.38 Mn
Jul 31, 2014 1.19 Mn
Oct 31, 2012 350.00
Jul 31, 2012 249,470.00
Apr 30, 2012 248,070.00
Jan 31, 2012 449,195.00
Oct 31, 2011 448,960.00
Jul 31, 2011 450,360.00